NewslettersCancer Stem Cell NewsNeural Cell News Erythrose Inhibits the Progression to Invasiveness and Reverts Drug Resistance of Cancer Stem Cells of Glioblastoma By Bob - March 1, 2023 0 Investigators evaluated the effect of the tetrose saccharide, erythrose, a neuroleukin inhibitor of invasiveness and drug sensitization in glioblastoma stem cells. [Medical Oncology] Abstract